Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.3M Buy
517,152
+434,227
+524% +$18.2M 0.04% 495
2026
Q1
$4.06M Buy
+82,925
New +$4.35M 0.01% 1130
2024
Q1
Sell
-21,859
Closed -$955K 2380
2023
Q4
$955K Buy
21,859
+4,236
+24% +$169K 0.01% 1012
2023
Q3
$807K Buy
+17,623
New +$798K 0.01% 1131
2023
Q2
Sell
-4,322
Closed -$231K 2528
2023
Q1
$231K Sell
4,322
-13,039
-75% -$711K ﹤0.01% 1860
2022
Q4
$1.19M Buy
+17,361
New +$1.17M 0.02% 849
2021
Q4
Sell
-78,876
Closed -$3.9M 3255
2021
Q3
$3.9M Buy
78,876
+64,068
+433% +$2.95M 0.02% 403
2021
Q2
$703K Buy
14,808
+2,815
+23% +$124K 0.01% 1478
2021
Q1
$415K Buy
+11,993
New +$444K ﹤0.01% 1926
2019
Q2
Sell
-11,750
Closed -$90K 756
2019
Q1
$90K Buy
+11,750
New +$104K 0.01% 442

Other funds holding CALX

HRT Financial's CALX Position: Q2 2026 in Review

HRT Financial increased its Calix (CALX) stake by 524% in Q2 2026, buying an estimated $18.2M and bringing the position to 517,152 shares worth $19.3M. The position accounts for 0.04% of the portfolio, ranked #495.

HRT Financial first reported a position in CALX in Q1 2019 and has held it in 10 quarters since. 285 funds tracked by Wall St. Rank hold CALX as of Q2 2026.

  • HRT Financial held 517,152 shares of Calix worth $19.3M as of Q2 2026.
  • HRT Financial bought 434,227 Calix shares in Q2 2026, an estimated $18.2M.
  • Calix made up 0.04% of HRT Financial's portfolio in Q2 2026, its #495 holding.
  • HRT Financial first reported a position in Calix in Q1 2019 and has held it in 10 quarters since.
  • 285 funds tracked by Wall St. Rank held Calix as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.